K. Tateishi

Application of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET Imaging to Predict Highly Malignant Tumor Grades and Hypoxia-Inducible Factor-1α Expression in Patients with Glioma

U. Tateishi, T. Inoue, N. Kawahara, 2013, American Journal of Neuroradiology.

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas

T. Maehara, T. Ushijima, K. Ichimura, 2016, Neuropathology and applied neurobiology.

62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET in Human Gliomas: Comparative Study with [18F]Fluorodeoxyglucose and L-Methyl-[11C]Methionine PET

U. Tateishi, K. Kubota, T. Inoue, 2014, American Journal of Neuroradiology.